Literature DB >> 10200472

Argos induces programmed cell death in the developing Drosophila eye by inhibition of the Ras pathway.

K Sawamoto1, A Taguchi, Y Hirota, C Yamada, M H Jin, H Okano.   

Abstract

We studied the role of Ras signaling in the regulation of cell death during Drosophila eye development. Overexpression of Argos, a diffusible inhibitor of the EGF receptor and Ras signaling, caused excessive cell death in developing eyes at pupal stages. The Argos-induced cell death was suppressed by coexpression of the anti-apoptotic genes p35, diap1, or diap2 in the eye as well as by the Df(3L)H99 chromosomal deletion that lacks three apoptosis-inducing genes, reaper, head involution defective (hid) and grim. Transient misexpression of the activated Ras1 protein (Ras1V12) later in pupal development suppressed the Argos-induced cell death. Thus, Argos-induced cell death seemed to have resulted from the suppression of the anti-apoptotic function of Ras. Conversely, cell death induced by overexpression of Hid was suppressed by gain-of-function mutations of the genes coding for MEK and ERK. These results support the idea that Ras signaling functions in two distinct processes during eye development, first triggering the recruitment of cells and later negatively regulating cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10200472     DOI: 10.1038/sj.cdd.4400342

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  18 in total

1.  Drob-1, a Drosophila member of the Bcl-2/CED-9 family that promotes cell death.

Authors:  T Igaki; H Kanuka; N Inohara; K Sawamoto; G Núñez; H Okano; M Miura
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  A Drosophila model of multiple endocrine neoplasia type 2.

Authors:  Renee D Read; Paul J Goodfellow; Elaine R Mardis; Nancy Novak; Jon R Armstrong; Ross L Cagan
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

Review 3.  Pattern formation in the Drosophila eye.

Authors:  Richard W Carthew
Journal:  Curr Opin Genet Dev       Date:  2007-07-06       Impact factor: 5.578

4.  Proapoptotic activity of Caenorhabditis elegans CED-4 protein in Drosophila: implicated mechanisms for caspase activation.

Authors:  H Kanuka; S Hisahara; K Sawamoto; S Shoji; H Okano; M Miura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

5.  The interaction between the Drosophila secreted protein argos and the epidermal growth factor receptor inhibits dimerization of the receptor and binding of secreted spitz to the receptor.

Authors:  M H Jin; K Sawamoto; M Ito; H Okano
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Mutations modulating the Argos-regulated signaling pathway in Drosophila eye development.

Authors:  A Taguchi; K Sawamoto; H Okano
Journal:  Genetics       Date:  2000-04       Impact factor: 4.562

7.  De novo synthesis of sphingolipids is required for cell survival by down-regulating c-Jun N-terminal kinase in Drosophila imaginal discs.

Authors:  T Adachi-Yamada; T Gotoh; I Sugimura; M Tateno; Y Nishida; T Onuki; H Date
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

8.  A screen for dominant modifiers of the irreC-rst cell death phenotype in the developing Drosophila retina.

Authors:  S B Tanenbaum; S M Gorski; J C Rusconi; R L Cagan
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

9.  scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila.

Authors:  Anthony M Brumby; Helena E Richardson
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

10.  Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage.

Authors:  Michael H Brodsky; Brian T Weinert; Garson Tsang; Yikang S Rong; Nadine M McGinnis; Kent G Golic; Donald C Rio; Gerald M Rubin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.